RealSeal

RealSeal is an ultra-rapid, absorbable hemostatic powder for immediate bleeding control in emergency and pre-hospital settings. Powered by our proprietary MACS technology, it rapidly absorbs blood and forms a physical barrier to stop bleeding—demonstrating 30–40% faster hemostasis compared to conventional solutions. Lightweight and easy to deploy, RealSeal supports human trauma care across emergency response, mass casualty incidents (MCI), and clinical settings, especially in situations where tourniquets are not effective.

Amelio Biomedical is a Taiwan-based medtech startup developing RealSeal, an ultra-rapid, absorbable hemostatic powder for severe bleeding control.
Powered by our proprietary MACS platform, RealSeal enables fast, effective hemostasis through a physical sealing mechanism.
We are targeting trauma care, emergency response, and field applications, with initial entry into the veterinary market before expanding to human use.